These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6088690

  • 1. Regional and cortical laminar distributions of serotonin S2, benzodiazepine, muscarinic, and dopamine D2 receptors in human brain.
    Luabeya MK, Maloteaux JM, Laduron PM.
    J Neurochem; 1984 Oct; 43(4):1068-71. PubMed ID: 6088690
    [Abstract] [Full Text] [Related]

  • 2. Spiroperidol, naloxone, diazepam and QNB binding in the monkey cerebral cortex.
    Divac I, Braestrup C, Nielsen M.
    Brain Res Bull; 1981 Nov; 7(5):469-77. PubMed ID: 6274480
    [No Abstract] [Full Text] [Related]

  • 3. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM, Janssen PF, Leysen JE.
    Eur J Pharmacol; 1982 Jun 16; 81(1):43-8. PubMed ID: 7117369
    [Abstract] [Full Text] [Related]

  • 4. Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex.
    Vogt BA, Plager MD, Crino PB, Bird ED.
    Neuroscience; 1990 Jun 16; 36(1):165-74. PubMed ID: 1977100
    [Abstract] [Full Text] [Related]

  • 5. Brain neurotransmitter receptor alterations in offspring of rats exposed to phenobarbital, phenytoin or their combination during pregnancy.
    Seth PK, Alleva FR, Takagi S, Yen-Koo HC, Balazs T.
    Neurotoxicology; 1987 Jun 16; 8(1):45-53. PubMed ID: 3031564
    [Abstract] [Full Text] [Related]

  • 6. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr 16; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

  • 7. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.
    Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P.
    Neuroscience; 1991 Apr 16; 40(3):657-71. PubMed ID: 2062437
    [Abstract] [Full Text] [Related]

  • 8. Changes in muscarinic cholinergic, PCP, GABAA, D1, and 5-HT2A receptor binding, but not in benzodiazepine receptor binding in the brains of aged rats.
    Nabeshima T, Yamada K, Hayashi T, Hasegawa T, Ishihara S, Kameyama T, Morimasa T, Kaneyuki T, Shohmori T.
    Life Sci; 1994 Apr 16; 55(20):1585-93. PubMed ID: 7968230
    [Abstract] [Full Text] [Related]

  • 9. Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior.
    Zeigler S, Lipton J, Toga A, Ellison G.
    Brain Res; 1991 Jun 21; 552(1):27-35. PubMed ID: 1655167
    [Abstract] [Full Text] [Related]

  • 10. Muscarinic and dopaminergic receptors in the aging human brain.
    Rinne JO.
    Brain Res; 1987 Feb 24; 404(1-2):162-8. PubMed ID: 3567563
    [Abstract] [Full Text] [Related]

  • 11. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM.
    Mol Pharmacol; 1985 Jun 24; 27(6):600-11. PubMed ID: 2860558
    [Abstract] [Full Text] [Related]

  • 12. Pituitary cell cultures contain muscarinic receptors.
    Taylor RL, Burt DR.
    Eur J Pharmacol; 1980 Jul 25; 65(2-3):305-8. PubMed ID: 6249627
    [Abstract] [Full Text] [Related]

  • 13. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA, Kim H, Marshall JF.
    J Pharmacol Exp Ther; 1985 May 25; 233(2):527-38. PubMed ID: 3889277
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
    Hietala J, Syvälahti E, Röyttä M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 May 25; 13(1-2):247-58. PubMed ID: 2526352
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G, Norman AB, Newton PL, Creese I.
    J Neurochem; 1986 Feb 25; 46(2):589-93. PubMed ID: 2934516
    [Abstract] [Full Text] [Related]

  • 16. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
    Syvälahti EK, Hietala J, Röyttä M, Grönroos J.
    Pharmacol Toxicol; 1988 Apr 25; 62(4):210-2. PubMed ID: 3387375
    [Abstract] [Full Text] [Related]

  • 17. Quantitative autoradiography of muscarinic and benzodiazepine receptors in the forebrain of the turtle, Pseudemys scripta.
    Schlegel JR, Kriegstein AR.
    J Comp Neurol; 1987 Nov 22; 265(4):521-9. PubMed ID: 2828438
    [Abstract] [Full Text] [Related]

  • 18. Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors.
    Maloteaux JM.
    Acta Neurol Belg; 1986 Nov 22; 86(2):61-129. PubMed ID: 2873704
    [Abstract] [Full Text] [Related]

  • 19. Environmental enrichment and neurotransmitter receptors.
    Por SB, Bennett EL, Bondy SC.
    Behav Neural Biol; 1982 Feb 22; 34(2):132-40. PubMed ID: 6123308
    [No Abstract] [Full Text] [Related]

  • 20. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
    Reynolds GP, Rossor MN, Iversen LL.
    J Neural Transm Suppl; 1983 Feb 22; 18():273-7. PubMed ID: 6135746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.